These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20453069)

  • 21. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
    Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
    Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.
    Cook D; Attia J; Weaver B; McDonald E; Meade M; Crowther M
    J Crit Care; 2000 Dec; 15(4):127-32. PubMed ID: 11138871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
    Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
    Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers.
    Khanna R; Maynard G; Sadeghi B; Hensley L; Medvedev S; Danielsen B; White RH
    J Hosp Med; 2014 Apr; 9(4):221-5. PubMed ID: 24497463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factor model to predict venous thromboembolism in hospitalized medical patients.
    Rothberg MB; Lindenauer PK; Lahti M; Pekow PS; Selker HP
    J Hosp Med; 2011 Apr; 6(4):202-9. PubMed ID: 21480491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Risk Assessment Model Predicts Major Bleeding Risk at Admission in Medical Inpatients.
    Mittman BG; Sheehan M; Kojima L; Cassachia N; Lisheba O; Hu B; Pappas M; Rothberg MB
    medRxiv; 2023 May; ():. PubMed ID: 37205327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H; Tar A;
    Orv Hetil; 2008 Nov; 149(44):2069-76. PubMed ID: 18952526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incidence of venous thromboembolism in men admitted to a pneumology unit for acute respiratory disease].
    Aissa I; Rachdi I; Ben Miled K; Ghedira H
    Rev Pneumol Clin; 2011 Jun; 67(3):129-35. PubMed ID: 21665075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
    Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
    Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study.
    Choffat D; Rossel JB; Aujesky D; Vollenweider P; Baumgartner C; Méan M
    J Thromb Haemost; 2024 Mar; 22(3):765-774. PubMed ID: 38072378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
    Moorehead KJ; Jeffres MN; Mueller SW
    J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospitalized women experiencing an episode of excessive oral anticoagulation had a higher bleeding risk than men.
    Cosma Rochat M; Waeber G; Wasserfallen JB; Nakov K; Aujesky D
    J Womens Health (Larchmt); 2009 Mar; 18(3):321-6. PubMed ID: 19281315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic medication use and bleeding risk in medically ill patients after hospitalization.
    Mahan CE; Spyropoulos AC; Fisher MD; Fields LE; Mills RM; Stephenson JJ; Fu AC; Klaskala W
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):504-12. PubMed ID: 23324537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism prophylaxis with anticoagulation in septic patients: a prospective cohort study.
    Zusman O; Paul M; Farbman L; Daitch V; Akayzen Y; Witberg G; Avni T; Gafter-Gvili A; Leibovici L
    QJM; 2015 Mar; 108(3):197-204. PubMed ID: 25190265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent.
    Piazza G; Seddighzadeh A; Goldhaber SZ
    Chest; 2007 Aug; 132(2):554-61. PubMed ID: 17573518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
    Amin AN; Girard F; Samama MM
    Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of thromboprophylaxis with enoxaparin in medical inpatients.
    Montero Ruiz E; Baldominos Utrilla G; López Álvarez J; Santolaya Perrin R
    Thromb Res; 2011 Nov; 128(5):440-5. PubMed ID: 21880352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.